<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11645">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01969006</url>
  </required_header>
  <id_info>
    <org_study_id>ILIOINGUINAL01</org_study_id>
    <nct_id>NCT01969006</nct_id>
  </id_info>
  <brief_title>Ilioinguinal Block in Laparoscopic Inguinal Hernia Repair</brief_title>
  <official_title>Effect of Ilioinguinal Blockage on Postoperative Pain After Laparoscopic Inguinal Herna Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Randers Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Surgery</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regionshospitalet Horsens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Randers Regional Hospital</source>
  <oversight_info>
    <authority>The Regional Committee on Biomedical Research Ethics: Denmark</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is undertaken to clarify whether intraoperative blockage with 40 ml of ½ %
      Marcaine© of the nerves in the ilio-inguinal canal may decrease postoperative pain after
      laparoscopic inguinal hernia repair.

      Patients will be randomised to injection of Marcaine© og a needle prick per-operatively.

      Pain will be estimated using the VAS score in:

      1. the wound 2  the abdomen 3  the shoulder

      Scoring will be performed:

        1. pre-operatively

        2. 1 hour postoperatively

        3. at discharge from the hospital d  day 1,2 and 3 post OP

      e. 1 year post OP
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      as above
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Post operative pain</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS score of pain from:
wound
abdomen
shoulder</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Post Operative Pain as Estimated by the Sue of the VAS Score</condition>
  <arm_group>
    <arm_group_label>Injection of Marcaine ½ %</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of 40 ml of Marcaine ½ % 2 cm medial, 2 cm downwards from the Anterior Iliac Spine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle prick</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Needle prick 2 cm medial and 2 cm downwards from the Anterior Iliac spine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Marcaine ½%</intervention_name>
    <arm_group_label>Injection of Marcaine ½ %</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Needle prick</intervention_name>
    <arm_group_label>Needle prick</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18 year

          2. Informed consent

          3. a diagnosis of an inguinal hernia

          4. ASA group ≤ 3

          5. BMI ≤ 35

        Exclusion Criteria:

          1. Communication problems

          2. No consent

          3. Open procedure (not laparoscopic)

          4. ASA-group 4

          5. Use of Steroid or immunosuppressive tretament

          6. Regular morphine use.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thorbjorn Sommer, MD, phd</last_name>
    <phone>+4523611376</phone>
    <email>thosom@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andersen Lars, MD, MPA</last_name>
    <phone>+45784500</phone>
    <email>larsande@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Horsens Regions Hospital</name>
      <address>
        <city>Horsens</city>
        <zip>8700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hans Fris Andersen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Randers regions Hospital</name>
      <address>
        <city>Randers</city>
        <zip>8900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Thorbjorn Sommer, MD, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 21, 2013</lastchanged_date>
  <firstreceived_date>October 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Randers Region Hospital</investigator_affiliation>
    <investigator_full_name>Thorbjorn Sommer</investigator_full_name>
    <investigator_title>Senior Surgeon phd, ass proffessor</investigator_title>
  </responsible_party>
  <keyword>inguinal hernia, postoperative pain, localanesthesia, nerve blockage</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
